KSK-67: 一种H3 receptor调节剂药物，由Uniwersytet Jagiellonski Collegium Medicum (Uniwersytet Jagiellonski Collegium Medicum)公司最早进行研发，目前全球最高研发状态为临床前，作用机制: H3 receptor调节剂(组胺H3受体调节剂)，在研机构: Uniwersytet Jagiellonski Collegium Medicum。

Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain. In search of new dual-acting histamine H 3 /sigma-1 receptor ligands, we designed a series of compounds structurally based on highly active in vivo ligands previously studied and described by our team.

KSK67 是一种高亲和力双重 sigma-2 和 组胺 H3 受体 拮抗剂，对 H3 受体、sigma-1、sigma-2 受体的 K 分别为 3.2, 1531, 101 nM。 KSK67 可用于伤害性疼痛和神经性疼痛的研究。 * Please select Quantity before adding items. s of 3.2, 1531, 101 nM for H3 receptor, sigma-1, sigma-2 receptor respectively. KSK67 can be used for research of nociceptive and neuropathic pain [1] .

KSK67 is a high-affinity dual sigma-2 and histamine H3 receptor antagonist, with Kis of 3.2, 1531, 101 nM for H3 receptor, sigma-1, sigma-2 receptor respectively. KSK67 can be used for research of nociceptive and neuropathic pain. - Mechanism of Action & Protocol.

KSK67 is a high-affinity dual sigma-2 and histamine H3 receptor antagonist, with Kis of 3.2, 1531, 101 nM for H3 receptor, sigma-1, sigma-2 receptor respectively. Buy Sigma Receptor inhibitor KSK67 from AbMole BioScience.

KSK67 is a high-affinity dual sigma-2 and histamine H3 receptor antagonist, with Kis of 3.2, 1531, 101 nM for H3 recepto

TargetMol提供 ksk 67 相关产品，覆盖了热门信号通路以及肿瘤、糖尿病、内分泌系统、神经系统、代谢等8个重点研究领域。 我们拥有CADD（计算机辅助药物设计）研究中心、药筛实验室、药化合成平台三大技术中心。

Synonym: KSK67; KSK-67; KSK 67 IUPAC/Chemical Name: cyclopropyl(4-(3-(4-(pyridin-4-yl)piperazin-1-yl)propoxy)phenyl)methanone InChi Key: MHFUOIGTIQCKRH-UHFFFAOYSA-N

KSK67 is a potent small molecule inhibitor of bacterial transcriptional activator PrfA with IC50 of 67 nM, reduces virulence factor expression in L. monocytogene.